|
TLN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.125700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.715700E-02 |
| Normal-vs-Stage2 |
2.242200E-01 |
| Normal-vs-Stage3 |
1.812480E-02 |
| Normal-vs-Stage4 |
1.293960E-01 |
| Stage1-vs-Stage2 |
9.090400E-01 |
| Stage1-vs-Stage3 |
2.946800E-01 |
| Stage1-vs-Stage4 |
9.741800E-01 |
| Stage2-vs-Stage3 |
4.479200E-01 |
| Stage2-vs-Stage4 |
9.476200E-01 |
| Stage3-vs-Stage4 |
4.412000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.874100E-02 |
| Normal-vs-AfricanAmerican |
7.578800E-01 |
| Normal-vs-Asian |
3.374800E-01 |
| Caucasian-vs-AfricanAmerican |
8.270300E-02 |
| Caucasian-vs-Asian |
5.191600E-01 |
| AfricanAmerican-vs-Asian |
2.992600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.505900E-02 |
| Normal-vs-Female |
6.582200E-02 |
| Male-vs-Female |
4.751600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203360E-01 |
| Normal-vs-Age(41-60Yrs) |
4.208200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.901600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.044800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.328400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.790400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.027600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.518000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.422800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.907400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.410770E-01 |
| Classical-VS-Follicular |
2.4285999999929E-05 |
| Classical-VS-Other |
4.104000E-02 |
| Classical-VS-Normal |
3.560000E-01 |
| Tall-VS-Follicular |
2.535600E-01 |
| Tall-VS-Other |
2.057600E-01 |
| Tall-VS-Normal |
5.666300E-02 |
| Follicular-VS-Other |
5.379400E-01 |
| Follicular-VS-Normal |
2.629300E-04 |
| Other-VS-Normal |
1.822370E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.388300E-02 |
| Normal-vs-N1 |
8.657200E-03 |
| N0-vs-N1 |
3.625400E-01 |
|
|
